Approximately four in five people living with hepatitis B and three out of four people with hepatitis C infection across the European Union and European Economic Area (EU/EEA) and the UK have not yet been diagnosed. This is a major obstacle on the way towards the Sustainable Development Goal (SDG) for health in 2030 as highlighted by ECDC on occasion of World Hepatitis Day.
For 2018, 30 EU/EEA Member States reported 24 588 cases of hepatitis B virus (HBV) infection. When the five countries that only reported acute cases are excluded, the number of cases is 24 034, which corresponds to a crude rate of 6.0 cases per 100 000 population.
This report provides the first collation of data relating to the monitoring of the progress towards the elimination of hepatitis B and C for EU/EEA countries.
The first report monitoring the progress towards the elimination of hepatitis B and C across European Union (EU) and European Economic Area (EEA) countries has been published by ECDC.
European Testing Week is a European campaign that encourages partner organisations, in community, health care and policy institutions, throughout Europe to unite for one week twice a year to increase testing efforts and promote awareness on the benefits of earlier hepatitis and HIV testing.
Data on antimicrobial resistance (AMR) in zoonotic and indicator bacteria from humans, animals and
food are collected annually by the EU Member States (MSs), jointly analysed by EFSA and ECDC and
reported in a yearly EU Summary Report.
This guidance on community engagement for public health emergency preparedness is intended for public health authorities in EU/EEA Member States. It is meant to provide step-by-step technical support to Member States who are initiating or professionalising their core community engagement capacity. The guidance is organised according to the three core stages of the preparedness cycle: anticipation, response, and recovery.